Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
High magnetic field reduces side-effect caused by anti-cancer drug imatinib
In recent research, a group led by Prof Zhang Xin at the High Magnetic Field Laboratory,…
Mushroom that grows on insects could help develop new anti-viral medications and cancer drugs
The Cordyceps mushroom is best known for its gruesome eating habits: famously, its spores infect insects and…
Statistics show an average of 789 new malignant cancers diagnosed a day in the UK in 2020
The Cancer Registration Statistics, England, 2020 publication provides information on cancers that were newly diagnosed in the…
IASLC WCLC 2020: CheckMate-743 shows that dual immunotherapy, nivolumab plus ipilimumab improves overall survival for patients with previously untreated mesothelioma
- IASLC WCLC 2020: Addition of sintilimab to pemetrexed and platinum improved progression-free survival in NSCLC
- IASLC WCLC 2020: Phase 3 eXalt3 study shows significantly longer progression-free survival in patients with ALK lung cancer
- Scientists accelerate progress in preventing drug resistance in lung and pancreas cancers
How a new breast cancer biomarker could help patients identify best treatment options
Dong-Xu Liu, Auckland University of Technology According to the latest GLOBOCAN cancer database, New Zealand’s breast cancer incidence rate is…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.